Clinical trial · Interventional
Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy
NCT06161233CI-TRIAL-00074854CAPABLE-ITcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the CAPABLE study is to compare health-related quality of life in renal cell carcinoma patients who use or do not use a mobile-based application to monitor adverse events for cancer treatment at home. As secondary objectives, the study investigates the usability of the system and its generalizability to other cancer types
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Ovary Cancer | — | UNRESOLVED | — |
| Renal Cell Carcinoma Metastatic | — | UNRESOLVED | — |
| Stomach Cancer | Malignant Gastric Neoplasm | CURATED_EXACT | 0.92 |
| Thyroid Cancer | Malignant Thyroid Gland Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CAPABLE cohort | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- CAPABLE cohort
- description
- Group that receives the CAPABLE mobile application and a smartwatch during treatment
- interventionNames
- Device: CAPABLE cohort
Primary outcomes (1)
- measure
- Change in health-related QoL outcomes in RCC patients
- timeFrame
- 6 months after the enrollment
- description
- The primary objective of this study is to investigate whether HRQoL of RCC patients eligible for systemic treatment can be improved by a patient-centred mobile coaching- and monitoring system
Secondary outcomes (2)
- measure
- User experience of the CAPABLE system in RCC patients
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (age \>=18 years) * Sufficient understanding of the Italian language * Patients or their caregiver (upon patient's consent) can use a smartphone * Histologically or cytologically confirmed diagnosis of RCC, lung, breast, thyroid o head and neck cancer * Candidate to systemic treatment (targeted agents, immune checkpoint inhibitors, or a combination of the two) * Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 at the start of the treatment. Exclusion Criteria: * Recruitment and consent denial * Not able of understanding and complying with the protocol requirements (including basic technological abilities) * Given the fact that each subject involved in the clinical study must be able to understand and sign the informed consent presented by the researcher, lack of this capability represents a specific exclusion criterion in the study protocol.
References
Publications (0)
Data not yet available
No reference posted for this study.